These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1570 related items for PubMed ID: 10480221

  • 21. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [Abstract] [Full Text] [Related]

  • 22. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC, Frystyk J, White DK, Twickler TB, Koppeschaar HP, Harris PE, Fryklund L, Murgatroyd PR, Dunger DB.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [Abstract] [Full Text] [Related]

  • 23. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 24. Derangements of the somatotropic hormone axis in chronic renal failure.
    Tönshoff B, Blum WF, Mehls O.
    Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
    [Abstract] [Full Text] [Related]

  • 25. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
    Rosenfalck AM, Fisker S, Hilsted J, Dinesen B, Vølund A, Jørgensen JO, Christiansen JS, Madsbad S.
    Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
    [Abstract] [Full Text] [Related]

  • 26. Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis.
    Ivarsen P, Chen JW, Tietze I, Christiansen JS, Flyvbjerg A, Frystyk J.
    Growth Horm IGF Res; 2010 Apr; 20(2):156-61. PubMed ID: 20044291
    [Abstract] [Full Text] [Related]

  • 27. Differential effects of growth hormone therapy in malnourished hemodialysis patients.
    Kotzmann H, Yilmaz N, Lercher P, Riedl M, Schmidt A, Schuster E, Kreuzer S, Geyer G, Frisch H, Hörl WH, Mayer G, Luger A.
    Kidney Int; 2001 Oct; 60(4):1578-85. PubMed ID: 11576376
    [Abstract] [Full Text] [Related]

  • 28. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R.
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [Abstract] [Full Text] [Related]

  • 29. Effect of a high-protein diet on ghrelin, growth hormone, and insulin-like growth factor-I and binding proteins 1 and 3 in subjects with type 2 diabetes mellitus.
    Gannon MC, Nuttall FQ.
    Metabolism; 2011 Sep; 60(9):1300-11. PubMed ID: 21406307
    [Abstract] [Full Text] [Related]

  • 30. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [Abstract] [Full Text] [Related]

  • 31. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant.
    Hokken-Koelega AC, Stijnen T, de Jong RC, Donckerwolcke RA, Groothoff JW, Wolff ED, Blum WF, de Muinck Keizer-Schrama SM, Drop SL.
    Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007
    [Abstract] [Full Text] [Related]

  • 32. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [Abstract] [Full Text] [Related]

  • 33. Effect of recombinant human growth hormone on intestinal absorption and body composition in children with short bowel syndrome.
    Goulet O, Dabbas-Tyan M, Talbotec C, Kapel N, Rosilio M, Souberbielle JC, Corriol O, Ricour C, Colomb V.
    JPEN J Parenter Enteral Nutr; 2010 May; 34(5):513-20. PubMed ID: 20852179
    [Abstract] [Full Text] [Related]

  • 34. Clinical experience in identical twins discordant for adult-onset growth hormone deficiency.
    Simpson H, Camcho-Hübner C, Sönksen P, Russell-Jones D.
    J Endocrinol Invest; 1999 May; 22(5 Suppl):61-3. PubMed ID: 10442573
    [Abstract] [Full Text] [Related]

  • 35. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
    Böni-Schnetzler M, Hauri C, Zapf J.
    Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
    [Abstract] [Full Text] [Related]

  • 36. Sustained low-dose growth hormone therapy optimizes bioactive insulin-like growth factor-I level and may enhance CD4 T-cell number in HIV infection.
    Andersen O, Hansen BR, Troensegaard W, Flyvbjerg A, Madsbad S, Ørskov H, Nielsen JO, Iversen J, Haugaard SB.
    J Med Virol; 2010 Feb; 82(2):197-205. PubMed ID: 20029798
    [Abstract] [Full Text] [Related]

  • 37. Evidence supporting a direct suppressive effect of growth hormone on serum IGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults.
    Nørrelund H, Fisker S, Vahl N, Børglum J, Richelsen B, Christiansen JS, Jørgensen JO.
    Growth Horm IGF Res; 1999 Feb; 9(1):52-60. PubMed ID: 10207508
    [Abstract] [Full Text] [Related]

  • 38. Systemic and splanchnic metabolic response to exogenous human growth hormone.
    Dahn MS, Lange MP.
    Surgery; 1998 May; 123(5):528-38. PubMed ID: 9591005
    [Abstract] [Full Text] [Related]

  • 39. Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysis.
    Iglesias P, Grande C, Méndez J, Fernandez-Reyes MJ, Bajo MA, Selgas R, Díez JJ.
    Adv Perit Dial; 1996 May; 12():71-6. PubMed ID: 8865877
    [Abstract] [Full Text] [Related]

  • 40. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
    Frystyk J, Skjaerbaek C, Zapf J, Orskov H.
    Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 79.